Compliance Certificate under Reg 74(5) of SEBI (DP) Regulations, 2018

Date: 28.07.2026 BSE Limited National Stock Exchange of India Ltd Floor 25, P J Towers Exchange Plaza, C-1, Block G, Dalal Street Bandra Kurla Complex, Bandra (E) Mumbai-400001 Mumbai – 400 051 BSE Code-531146 NSE Code: MEDICAMEQ Sub: Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended on June 30, 2026 Dear Sir / Madam This is to inform that the details of securities dematerialized / rematerialized during the quarter ended on June 30, 2026, as required under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 have been furnished by our Registrar and Share Transfer Agent to all the Stock Exchanges, where the shares of the Company are listed (copy enclosed). We hereby confirm and certify that: (a) The securities comprised in the said certificates(s) have been listed on the stock exchanges or exchanges were the earlier issued securities were listed; and (b) The certificates have been mutilated and cancelled after due verification and the name of the depository has been substituted in our records as the registered owner within 30 days of its receipt. Thanking you Yours truly For Medicamen Biotech Limited Parul Choudhary Company Secretary ACS-44157